Cross-source evidence timeline

Survodutide research timeline

Follow 18 selected, directly cited source records from June 25, 2025 through November 16, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

18Selected records
2Source years
2Evidence lanes
November 16, 2026Latest source date

Source year

2026

17 records
  1. Clinical trials

    ClinicalTrials.gov record NCT07940244↗

    PeptideScanner retained ClinicalTrials.gov record NCT07940244 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was survodutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT07754461↗

    PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was survodutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT06077864↗

    PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT06632457↗

    PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT07850063↗

    PeptideScanner retained ClinicalTrials.gov record NCT07850063 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT07850050↗

    PeptideScanner retained ClinicalTrials.gov record NCT07850050 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was survodutide.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT07768813↗

    PeptideScanner retained ClinicalTrials.gov record NCT07768813 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was survodutide.↗

  8. Clinical trials

    ClinicalTrials.gov record NCT07221591↗

    PeptideScanner retained ClinicalTrials.gov record NCT07221591 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide.↗

  9. Clinical trials

    ClinicalTrials.gov record NCT07855900↗

    PeptideScanner retained ClinicalTrials.gov record NCT07855900 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide.↗

  10. Literature metadata

    Interpreting Survodutide Renoprotection in a Hyperfiltration Model.↗

    PubMed lists PMID 42897119 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2026-10-19 (day precision). PeptideScanner associated the retained record with the identity slug survodutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  11. Clinical trials

    ClinicalTrials.gov record NCT06632444↗

    PeptideScanner retained ClinicalTrials.gov record NCT06632444 at 2026-08-13T05:52:27.024Z. Its registry update date was 2026-08-10, and PeptideScanner's reviewed identity mapping was survodutide.↗

  12. Clinical trials

    Survodutide liver-activity study record updated↗

    ClinicalTrials.gov lists an active, not recruiting Survodutide study sponsored by Boehringer Ingelheim.↗

  13. Clinical trials

    ClinicalTrials.gov record NCT07413913↗

    PeptideScanner retained ClinicalTrials.gov record NCT07413913 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was survodutide.↗

  14. Clinical trials

    ClinicalTrials.gov record NCT06176365↗

    PeptideScanner retained ClinicalTrials.gov record NCT06176365 at 2026-07-30T16:20:49.317Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.↗

  15. Clinical trials

    ClinicalTrials.gov record NCT06309992↗

    PeptideScanner retained ClinicalTrials.gov record NCT06309992 at 2026-07-30T16:20:49.307Z. Its registry update date was 2026-04-30, and PeptideScanner's reviewed identity mapping was survodutide.↗

  16. Literature metadata

    PubMed record PMID 41388343↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41388343 at 2026-07-30T16:25:14.127Z. PubMed recorded a metadata revision date of 2026-02-14 and an Entrez history date of 2025-12-13. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.↗

  17. Literature metadata

    PubMed record PMID 41424209↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 41424209 at 2026-07-30T16:25:14.150Z. PubMed recorded a metadata revision date of 2026-02-10 and an Entrez history date of 2025-12-22. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.↗

Source year

2025

1 record
  1. Literature metadata

    PubMed record PMID 40557206↗

    PeptideScanner retained PubMed bibliographic metadata for PMID 40557206 at 2026-07-30T18:26:54.791Z. PubMed recorded a metadata revision date of 2025-06-25 and an Entrez history date of 2025-06-25. PeptideScanner associated this retained record with the identity slug survodutide. These dates describe PubMed metadata history, not the article's original publication date.↗